Espolong, Gino E.
HRN: 24-48-19 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2024
CEFTRIAXONE 1G (VIAL)
02/05/2024
02/11/2024
IV
2g
Q12
T/C CNS Infection
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes